Personalized Medication Management and Impairment Mitigation System

Publication ID: 24-11857325_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Medication Management and Impairment Mitigation System,” Published Technical Disclosure No. 24-11857325_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857325_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,325.

Summary of the Inventive Concept

A next-generation system for predicting and mitigating medication-induced impairment, leveraging AI, IoT, and wearable technologies to ensure safer and more effective medication management.

Background and Problem Solved

The original patent disclosed a system for monitoring medication usage and assessing a user's impairment in relation to driving a vehicle. However, this system had limitations in terms of predicting impairment and providing personalized medication management. The new inventive concept addresses these limitations by integrating advanced technologies to provide real-time monitoring, predictive analytics, and customized treatment plans.

Detailed Description of the Inventive Concept

The system comprises a wearable sensor that tracks a user's vital signs and medication usage, a machine learning module that analyzes the sensor data to predict the likelihood of impairment, and a notification module that alerts the user or a designated party when impairment is predicted. The system may also include a smart contact lens that monitors glucose levels, a network of IoT-enabled medication containers, and a cloud-based analytics platform. The system's advanced analytics and machine learning capabilities enable personalized medication management, minimizing the risk of impairment.

Novelty and Inventive Step

The new claims introduce a paradigm shift in medication management by leveraging AI, IoT, and wearable technologies to predict and mitigate impairment. The integration of these technologies provides a non-obvious solution to the problem of medication-induced impairment, going beyond the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the system may include different types of wearable sensors, such as implantable devices or smart patches. The system may also be integrated with other health monitoring devices, such as fitness trackers or mobile apps. Additionally, the system's predictive analytics module may be adapted for use in other industries, such as transportation or healthcare.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare and pharmaceutical industries, particularly in the areas of medication management, patient safety, and personalized medicine. The system may also have applications in the transportation industry, such as in the development of autonomous vehicles or ride-sharing services.

Field of Art

Medical device technology, specifically medication management systems with impairment monitoring and assessment technologies, requiring expertise in biomedical engineering, sensor technologies, data analytics, and medical informatics

Person of Ordinary Skill (PHOSITA) Profile

A professional with a graduate degree in biomedical engineering or related field, experienced in developing medical monitoring systems, familiar with IoT sensor technologies, machine learning applications in healthcare, and regulatory compliance for medical device innovations

Obviousness Rationale

A person having ordinary skill would recognize that the PTD represents a predictable technological evolution of the source patent's core concept of medication and impairment monitoring, utilizing well-known techniques in sensor integration, machine learning, and personalized healthcare analytics to extend the original system's capabilities.

Obvious Combinations & Variations

Source Patent Element
Injection monitoring device configured to measure dosing information
PTD Variation
IoT-enabled medication containers transmitting usage data to cloud-based analytics platform
Obviousness Reasoning
Extending data collection methods using standard IoT communication protocols represents a known technique for improving monitoring granularity and accessibility
Source Patent Element
User monitoring device configured to monitor physiological condition
PTD Variation
Wearable sensor tracking vital signs with machine learning impairment prediction
Obviousness Reasoning
Applying machine learning to physiological monitoring is a predictable technological progression using standard data analysis techniques in medical monitoring systems
Source Patent Element
Medical monitoring device assessing driving ability level
PTD Variation
Smart contact lens monitoring glucose levels and providing real-time feedback
Obviousness Reasoning
Integrating additional physiological monitoring into existing impairment assessment systems represents an obvious design optimization using known sensor technologies
Source Patent Element
System for communicating driving ability level
PTD Variation
Notification module alerting user or designated party about predicted impairment risks
Obviousness Reasoning
Expanding communication protocols for medical monitoring represents a logical and predictable system enhancement using standard alert technologies
Source Patent Element
Monitoring device storing and updating dosing information
PTD Variation
Analyzing user's genetic profile and medical history to generate customized treatment plan
Obviousness Reasoning
Incorporating personalized medical data analysis is a foreseeable extension of existing medical monitoring technologies using established data integration techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857325, the present publication demonstrates that the claimed variations in medication monitoring and impairment assessment technologies would have been obvious to a person having ordinary skill in the art at the time of invention, as the disclosed innovations represent predictable technological extensions utilizing known sensor, data analytics, and communication techniques in medical device monitoring systems.

Original Patent Information

Patent NumberUS 11,857,325
TitleDevice for managing a medication regime
Assignee(s)Sanofi